Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

See How the New ClinOne Connects, Informs and Empowers Patients in Complex Clinical Trials at the SCOPE Summit for Clinical Ops Execs

Medpace and ClinOne join to discuss 5 barriers to patient enrollment we can remove in 2022


News provided by

ClinOne

Feb 07, 2022, 04:00 ET

Share this article

Share toX

Share this article

Share toX


DENVER, Feb. 7, 2022 /PRNewswire-PRWeb/ -- At the SCOPE Summit (Feb 7-10, 2022), ClinOne will unveil its new brand, product marketecture, and messaging – and showcase how its mission to connect, inform and empower clinical trials patients is making it one of the fastest growing companies to watch in clinical technology.

"If anything is clear since the last SCOPE two years ago, it's that 'good enough' is no longer good enough," said Kristopher Sarajian (LinkedIn), VP of Marketing at ClinOne. "Remote solutions, technology standards, delivery timelines, flexible integrations, and UX have all taken massive steps forward. So, while it's easy to dismiss a rebrand as a new logo, colors, and website – and we'll certainly have all that – at this pivotal moment in the evolution of clinical trials it represents much more. That's why I'm excited for you to meet the new ClinOne. Together, we will provide the results you need – and the experience your patients deserve."

I’m excited for you to meet the new ClinOne at SCOPE.It’s not about what clinical trial tech providers do; it’s about what you’ll achieve for patients, sites and study teams.Together we’ll provide results you need and the experience your patients deserve. –Kristopher Sarajian, ClinOne VP, Marketing

Post this

ClinOne will have an active role at the SCOPE Summit. In addition to the rebrand…

  • Subject matter experts will showcase ClinOne's true single platform for eConsent, HCP trial awareness, Uber Health, medication adherence, and DCT patient portal at exhibit booth #421
  • ClinOne and Medpace will co-present an important session, "5 Obstacles to Patient Enrollment We Can Remove in 2022," on Wednesday, February 9 at 8:55am
  • Clinical operations professionals can schedule a meeting with experienced technology leaders including Rob Bohacs, Keli Platco, and Richard Gross
  • Founder and Chief Solutions Officer Rob Bohacs will Chair the recruitment and enrollment tracks on the mornings of February 9 and 10
  • Visitors to the ClinOne booth will pick up a Crumbee™ (the summit's best giveaway to keep your WFH desk clean) and enter for a chance to win an Oculus Quest 2

SCOPE Session Details: 5 Obstacles to Patient Enrollment We Can Remove in 2022

Rob Bohacs (ClinOne) and Amanda Siegert (Associate Director, Patient Recruitment at Medpace) will discuss five simple things we can implement today to make it easier for patients to say "yes" to participating (and staying) in clinical trials. Topics to explore in this session include activating HCP communities to raise trial awareness, going remote without leaving out clinical sites, technology for empowerment and empathy, the importance of patient payments, and caregiver support and family engagement. The session will be held on February 9 at 8:55am in the Enrollment Planning and Patient Recruitment track (Gatlin A1)

In case you haven't seen ClinOne lately, the company made news in 2021 with…

  • A second consecutive year of 120%+ revenue growth
  • A medication adherence interactive SMS solution that achieved up to 98% compliance on a Phase III elderly cardiovascular trial
  • Achieving 96% on-time delivery while meeting aggressive goals for some of the fastest deployment timelines in the industry (~2-4 weeks)
  • New webhooks for its already-leading eConsent API that integrate directly into existing clinical systems, with real-time data transfer
  • Solutions to simplify complex clinical trials for patients, caregivers, and sites, with more than 50% of the company's experience in Oncology and Rare Disease

"The truth is, it's not what we do, or what any technology provider does, that matters – it's about what you will achieve for your patients, sites, and study teams," added Sarajian. "Year in and year out, there is no better forum than the SCOPE Summit to meet with colleagues at sponsors, CROs, and other technology providers to share ideas, learn from each other, and brainstorm new solutions. There is simply no better place for a brand launch and for meaningful conversations than SCOPE – and personally, I can't wait to see everyone again."

Learn how ClinOne will help you connect, inform, and empower patients to get the results you need, and the experience patients deserve, at http://www.clinone.com.

About ClinOne
ClinOne is the patient relationship company for clinical trials. More than 50 leading pharmaceutical companies and CROs trust us to CONNECT, INFORM, and EMPOWER patients to help them take control of their clinical trial experience. Our single technology platform includes proven solutions for peer referrals, eConsent, virtual visits, Uber Health, dosing management, eDiaries, and more – featuring unrivaled remote capabilities, cost-efficient deployment, and the industry's fastest implementation timelines. ClinOne is led by a team of global experts with decades of success running global trials for many of the largest technology providers. How can we help you improve clinical trials for patients, caregivers, sites, and study teams? Let's get creative at http://www.clinone.com.

Media Contact

Brenda Nashawaty, ClinOne, +1 617.688.3253, [email protected]

SOURCE ClinOne

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.